Moreover, Ccr5-/- CTLs exhibited a reduced capacity to eliminate cognate tumour masses (Figure 5—figure supplement 1F,G), despite fully functional antigen-specific cytotoxicity (Figure 5—figure supplement 1H) and chemokine secretion (Figure 5—figure supplement 1I). This evidence concerns the gene CCR5 and neoplasm.